These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. FDA approves fomivirsen, famciclovir, and Thalidomide. Food and Drug Administration. Highleyman L BETA; 1998 Oct; ():5. PubMed ID: 11365993 [TBL] [Abstract][Full Text] [Related]
9. New CMV drug won't replace other therapies. AIDS Alert; 1998 Nov; 13(11):124-6. PubMed ID: 11365968 [TBL] [Abstract][Full Text] [Related]
14. A randomized controlled clinical trial of intravitreous fomivirsen for treatment of newly diagnosed peripheral cytomegalovirus retinitis in patients with AIDS. Vitravene Study Group Am J Ophthalmol; 2002 Apr; 133(4):467-74. PubMed ID: 11931780 [TBL] [Abstract][Full Text] [Related]
15. Fomivirsen. Perry CM; Balfour JA Drugs; 1999 Mar; 57(3):375-80; discussion 381. PubMed ID: 10193689 [TBL] [Abstract][Full Text] [Related]
16. Reversible bull's-eye maculopathy associated with intravitreal fomivirsen therapy for cytomegalovirus retinitis. Stone TW; Jaffe GJ Am J Ophthalmol; 2000 Aug; 130(2):242-3. PubMed ID: 11004306 [TBL] [Abstract][Full Text] [Related]
17. Safety of intravitreous fomivirsen for treatment of cytomegalovirus retinitis in patients with AIDS. Vitravene Study Group. Am J Ophthalmol; 2002 Apr; 133(4):484-98. PubMed ID: 11931782 [TBL] [Abstract][Full Text] [Related]
18. FDA grants marketing clearance of Vistide for the treatment of CMV retinitis. AIDS Patient Care STDS; 1996 Dec; 10(6):383-4. PubMed ID: 11361576 [No Abstract] [Full Text] [Related]
19. FDA notifications. FDA approves generic foscarnet sodium injection. AIDS Alert; 2005 Jul; 20(7):82. PubMed ID: 16110563 [No Abstract] [Full Text] [Related]
20. Cidofovir recommended for approval for CMV retinitis. James JS AIDS Treat News; 1996 Apr; (no 244):6-7. PubMed ID: 11363308 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]